Zentiva Group a.s.

Zentiva · Companies & groups · CZ

Kategorija
Companies & groups
Būstinė
Praha 10 CZ
Registruota
2023-11-02
Deklaruotos metinės išlaidos
50 000–99 999 € (pačios deklaruota)
Svetainė
www.zentiva.com
Skaidrumo registras
888725551808-41 ↗
Susitikimai su EK
Pateiktos pozicijos
0
Pozicijos dokumentai
0
Paminėjimai spaudoje
Sumą deklaruoja pati organizacija Skaidrumo registre; institucijos jos netikrina.

Susitikimai pagal metus

202322025320262

Šaltinis: Europos Komisijos skelbiami susitikimai, sutapatinti pagal skaidrumo registro numerį. n = 7 susitikimų; x — metai pagal susitikimo datą, y — susitikimų skaičius.

Susitikimai su Europos Komisija

Skelbiami tik susitikimai su Komisijos nariais, jų kabinetais ir generaliniais direktoriais. Susitikimai žemesniu lygiu ir daugelis kontaktų Parlamente bei Taryboje į registrą nepatenka.
DataPriėmėTema
2026-07-09Cabinet of Commissioner Olivér VárhelyiSustainability of European pharmaceutical manufacturing
2026-07-09Cabinet of Commissioner Olivér VárhelyiSustainability of European pharmaceutical manufacturing
2025-10-28Cabinet of Commissioner Maroš ŠefčovičPriorities of the EU’s trade agenda
2025-10-28Cabinet of Commissioner Maroš ŠefčovičPriorities of the EU’s trade agenda
2025-10-28Cabinet of Commissioner Maroš ŠefčovičPriorities of the EU’s trade agenda
2023-11-23Cabinet of Vice-President Věra JourováCompetitiveness, green and digital transition
2023-11-23Cabinet of Vice-President Věra JourováCompetitiveness, green and digital transition

Ką pateikė viešoms konsultacijoms

2025-09-10 · Simplification of administrative burdens in environmental legislation ↗ originalus šaltinis
Zentiva is a pharmaceutical manufacturer focused on Europe with production sites in Prague (Czech Republic) and Bucharest (Romania), supplying affordable and essential medicines to more than 100 million patients across Europe every year. We fully support the ambition of the European Green Deal. As a company focused on affordable, off-patent and critical medicines, we are committed to strengthening Europes health security and supply chain resilience as well as measures to improve water quality. However, the Extended Producer Responsibility (EPR) scheme under the revised Urban Wastewater Treatment Directive (UWWTD) raises serious concerns regarding proportionality and non-discrimination. It…

Kokias ES temas nurodo sekanti

Healthcare generally, Public Health, Industiral Affairs, Medicines Production, Pharmaceutical legisltion, Pricing and Reimbursement Policies.
Mainly Pharmaceutical Legislation:
- Regulation 726/2004
- Directive 2001/83/EC
- Regulation 1901/2006
- Regulation 141/2000/EC
- Regulation 2025/0102
Industrial:
- The Urban Waste Water Treatment Directive (UWWTD) - Council Directive 91/271/EEC